Exhibit 1.2 COMMON STOCK PURCHASE AGREEMENT Dated as of August 15, 2001 by and between BIOMARIN PHARMACEUTICAL INC.Common Stock Purchase Agreement • August 16th, 2001 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Exhibit 10.1 August 10, 2001 Acqua Wellington North American Equities Fund, Ltd. c/o Fortis Fund Services (Bahamas) Ltd. Montague Sterling Centre East Bay Street, P.O. Box SS-6238 Nassau, Bahamas Re: Termination of the Common Stock Purchase Agreement...Biomarin Pharmaceutical Inc • August 16th, 2001 • Pharmaceutical preparations
Reference is made to the Common Stock Purchase Agreement dated January 26, 2001 (the "Purchase Agreement"), by and between BioMarin Pharmaceutical Inc. ("BioMarin") and Acqua Wellington North American Equities Fund, Ltd. (collectively, the "parties"). Pursuant to Section 7.1 of the Purchase Agreement, the parties mutually agree to terminate the Purchase Agreement. Any draw down issued under the Purchase Agreement which has not been settled in accordance with the terms of the Purchase Agreement on or prior to the date hereof is hereby terminated and shall be null and void. Notwithstanding anything to the contrary contained herein, BioMarin shall have no liability under Section 9.1(b) of the Purchase Agreement in connection with the termination of the Purchase Agreement pursuant hereto. The termination of the Purchase Agreement will be effective as of the date of this letter.
